Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Exercise × Tumor-Agnostic × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Lymphoid 3 Plasma cell 2 Other hematologic neoplasm 2 Genitourinary 2 Tumor-Agnostic 1 Thoracic 1 Dermatologic 1 CNS 1

Conditions

Interventions

Specimen Handling 18 Biopsy 17 pembrolizumab 14 Magnetic Resonance Spectroscopy 14 Carboplatin 8 Paclitaxel 7 Nivolumab 7 Cisplatin 7 Bevacizumab 7 atezolizumab 6 Gemcitabine 6 Taxes 5 Pemetrexed 5 Capecitabine 5 trastuzumab deruxtecan 4 Docetaxel 4 Blood Specimen Collection 4 relatlimab 3 osimertinib 3 nilotinib 3 ipatasertib 3 durvalumab 3 X-Rays 3 Trastuzumab 3 Surveys and Questionnaires 3 Standard of Care 3 Radiosurgery 3 Oxaliplatin 3 Leucovorin 3 Ipilimumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05539794 2026-03-23

EXERCADOL

Universidad Europea de Madrid

Phase NA Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡